Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
kr136.52 Mil
% of Total Estimate Gain
68.58%

AST J.P. Morgan Conservative Multi-Asset Portfolio's Novo Nordisk AS Holding Summary

As of 2025-03-31, AST J.P. Morgan Conservative Multi-Asset Portfolio held - shares of Novo Nordisk AS(OCSE:NOVO B), totaling N/A. This investment constitutes 0% of their stock portfolio, and AST J.P. Morgan Conservative Multi-Asset Portfolio now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2019Q3. And since then AST J.P. Morgan Conservative Multi-Asset Portfolio has made 10 purchases of OCSE:NOVO B, at an average price of kr285.32, for a total of 697,654.00 shares. In addition, there have been 11 sales at an average price of kr481.01 for 697,654.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr451.30, AST J.P. Morgan Conservative Multi-Asset Portfolio's estimated gain on his OCSE:NOVO B holdings is kr136.52 Mil, reflecting a 68.58% gain to date.

AST J.P. Morgan Conservative Multi-Asset Portfolio OCSE:NOVO B (kr451.30) Holding Chart

AST J.P. Morgan Conservative Multi-Asset Portfolio OCSE:NOVO B (kr451.30) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1